2018
DOI: 10.1371/journal.pone.0194728
|View full text |Cite
|
Sign up to set email alerts
|

Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver

Abstract: Viral vectors are extensively purified for use in biomedical research, in order to separate biologically active virus particles and to eliminate production related impurities that are assumed to be detrimental to the host. For recombinant adeno-associated virus (rAAV) vectors this is typically accomplished using density gradient-based methods, which are tedious and require specialized ultracentrifugation equipment. In order to streamline the preparation of rAAV vectors for pilot and small animal studies, we re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…The OHSU Molecular Virology Support Core produced large-scale preparations of recombinant rAAV2/8 viruses, referenced as rAAV2/8_LSP_SpCas9 and AAV2/ 8_Ex7RepairTemp_U6G1, using standard triple plasmid transfection procedures into cultured HEK293 cells and purified by iodixanol gradient ultracentrifugation. 49 AAV titers were determined using ITR-based qPCR analysis.…”
Section: Viral Productionmentioning
confidence: 99%
“…The OHSU Molecular Virology Support Core produced large-scale preparations of recombinant rAAV2/8 viruses, referenced as rAAV2/8_LSP_SpCas9 and AAV2/ 8_Ex7RepairTemp_U6G1, using standard triple plasmid transfection procedures into cultured HEK293 cells and purified by iodixanol gradient ultracentrifugation. 49 AAV titers were determined using ITR-based qPCR analysis.…”
Section: Viral Productionmentioning
confidence: 99%
“…via tail vein with an AAV2/8 virus encoding the full-length murine Tfr2 ORF under the regulation of a hepatocyte-specific promoter (AAV2/8-Tfr2). PBS-injected mice were used as controls because previously published PBS-and AAV2/8-GFP-injected mice indicated no differences in responses to any of the parameters measured (37,38). RT-quantitative PCR and Western blot analysis confirmed liver-specific expression of TFR2 3 weeks after injection (Fig.…”
Section: Tfr2 Deficiency Increases Erythroid Progenitor Populationsmentioning
confidence: 62%
“…This method did not affect either the efficiency of transduction in mouse liver cells or the induction of inflammation after systemic delivery. [ 94 ]…”
Section: Nonspecific Raav Purification Approachesmentioning
confidence: 99%